Dr Richard Good
- Clinical Senior Lecturer in Ischaemic Heart Disease/Honorary Consultant (Cardiovascular & Metabolic Health)
- Honorary Clinical Senior Lecturer (School of Cardiovascular & Metabolic Health)
telephone:
01413308015
email:
Richard.Good@glasgow.ac.uk
School of Cardiovascular & Metabolic Health, University of Glasgow, University Place, Glasgow, United Kingdom, G12 8TA
Research interests
Publications
2025
Jaubert, Olivier, Mohammadi, Salman, Goatman, Keith A., Mikhael, Shadia S., Bradley, Conor, Hughes, Rebecca, Good, Richard, Hipwell, John H. and Dahdouh, Sonia (2025) Conformal Coronary Calcification Volume Estimation with Conditional Coverage via Histogram Clustering. 2025 IEEE 22nd International Symposium on Biomedical Imaging (ISBI), Houston, TX, USA, 14-17 April 2025. pp. 1-5. ISBN 9798331520526 (doi: 10.1109/isbi60581.2025.10980751)
Renon, Silvia, Ramses, Rafic, Aggarwal, Ankush 
ORCID: https://orcid.org/0000-0002-1755-8807, Good, Richard and Mcginty, Sean ORCID: https://orcid.org/0000-0002-2428-2669
(2025)
Drug coated balloons in percutaneous coronary intervention: how can computational modelling help inform evolving clinical practice?
Frontiers in Medical Technology, 7,
1546417.
(doi: 10.3389/fmedt.2025.1546417)
Carberry, J. et al. (2025) Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI). European Journal of Heart Failure, 27(3), pp. 566-576. (doi: 10.1002/ejhf.3560) (PMID:39675781) (PMCID:PMC11955320)
2024
Ang, D. T.Y. et al. (2024) Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial. Heart, (doi: 10.1136/heartjnl-2024-324677) (PMID:39603791) (Early Online Publication)
Carberry, J. et al. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure, 11(4), pp. 2001-2012. (doi: 10.1002/ehf2.14830) (PMID:38715187) (PMCID:PMC11287338)
Ramses, Rafic, Kennedy, Simon ORCID: https://orcid.org/0000-0003-0887-5840, Good, Richard, Oldroyd, Keith G. and Mcginty, Sean ORCID: https://orcid.org/0000-0002-2428-2669
(2024)
Performance of drug-coated balloons in coronary and below-the-knee arteries: anatomical, physiological and pathological considerations.
Vascular Pharmacology, 155,
107366.
(doi: 10.1016/j.vph.2024.107366)
(PMID:38479462)
2023
Bradley, C. P. et al. (2023) The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design. American Heart Journal, 265, pp. 213-224. (doi: 10.1016/j.ahj.2023.08.067) (PMID:37657593)
Ohashi, H. et al. (2023) Fractional flow reserve guided stent optimisation in focal and diffuse coronary artery disease. Diagnostics, 13(15), 2612. (doi: 10.3390/diagnostics13152612) (PMID:37568975) (PMCID:PMC10417445)
Collison, D. et al. (2023) Angina after percutaneous coronary intervention: patient and procedural predictors. Circulation: Cardiovascular Interventions, 16(4), e012511. (doi: 10.1161/CIRCINTERVENTIONS.122.012511) (PMID:36974680) (PMCID:PMC10101135)
Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. British Society of Cardiovascular Magnetic Resonance (BSCMR) 17th Annual Congress, Liverpool, UK, 11-12 Oct 2022. (doi: 10.1136/heartjnl-2022-BSCMR.26)
2022
Ford, T. J. et al. (2022) Coronary artery perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study. Journal of the American Heart Association, 11(19), e024492. (doi: 10.1161/JAHA.121.024492) (PMID:36129052) (PMCID:PMC9673697)
Articles
Renon, Silvia, Ramses, Rafic, Aggarwal, Ankush ORCID: https://orcid.org/0000-0002-1755-8807, Good, Richard and Mcginty, Sean ORCID: https://orcid.org/0000-0002-2428-2669
(2025)
Drug coated balloons in percutaneous coronary intervention: how can computational modelling help inform evolving clinical practice?
Frontiers in Medical Technology, 7,
1546417.
(doi: 10.3389/fmedt.2025.1546417)
Carberry, J. et al. (2025) Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI). European Journal of Heart Failure, 27(3), pp. 566-576. (doi: 10.1002/ejhf.3560) (PMID:39675781) (PMCID:PMC11955320)
Ang, D. T.Y. et al. (2024) Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial. Heart, (doi: 10.1136/heartjnl-2024-324677) (PMID:39603791) (Early Online Publication)
Carberry, J. et al. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure, 11(4), pp. 2001-2012. (doi: 10.1002/ehf2.14830) (PMID:38715187) (PMCID:PMC11287338)
Ramses, Rafic, Kennedy, Simon ORCID: https://orcid.org/0000-0003-0887-5840, Good, Richard, Oldroyd, Keith G. and Mcginty, Sean ORCID: https://orcid.org/0000-0002-2428-2669
(2024)
Performance of drug-coated balloons in coronary and below-the-knee arteries: anatomical, physiological and pathological considerations.
Vascular Pharmacology, 155,
107366.
(doi: 10.1016/j.vph.2024.107366)
(PMID:38479462)
Bradley, C. P. et al. (2023) The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design. American Heart Journal, 265, pp. 213-224. (doi: 10.1016/j.ahj.2023.08.067) (PMID:37657593)
Ohashi, H. et al. (2023) Fractional flow reserve guided stent optimisation in focal and diffuse coronary artery disease. Diagnostics, 13(15), 2612. (doi: 10.3390/diagnostics13152612) (PMID:37568975) (PMCID:PMC10417445)
Collison, D. et al. (2023) Angina after percutaneous coronary intervention: patient and procedural predictors. Circulation: Cardiovascular Interventions, 16(4), e012511. (doi: 10.1161/CIRCINTERVENTIONS.122.012511) (PMID:36974680) (PMCID:PMC10101135)
Ford, T. J. et al. (2022) Coronary artery perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study. Journal of the American Heart Association, 11(19), e024492. (doi: 10.1161/JAHA.121.024492) (PMID:36129052) (PMCID:PMC9673697)
Conference or Workshop Item
Jaubert, Olivier, Mohammadi, Salman, Goatman, Keith A., Mikhael, Shadia S., Bradley, Conor, Hughes, Rebecca, Good, Richard, Hipwell, John H. and Dahdouh, Sonia (2025) Conformal Coronary Calcification Volume Estimation with Conditional Coverage via Histogram Clustering. 2025 IEEE 22nd International Symposium on Biomedical Imaging (ISBI), Houston, TX, USA, 14-17 April 2025. pp. 1-5. ISBN 9798331520526 (doi: 10.1109/isbi60581.2025.10980751)
Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. British Society of Cardiovascular Magnetic Resonance (BSCMR) 17th Annual Congress, Liverpool, UK, 11-12 Oct 2022. (doi: 10.1136/heartjnl-2022-BSCMR.26)
Grants
Grants and Awards listed are those received whilst working with the University of Glasgow.
- EPSRC Centre for Future PCI Planning
Engineering and Physical Sciences Research Council
2024 - 2028
- Quantification of heart artery calcification in contrast enhanced, non-cardiac CT scans: A comparison with the Agatston score derived from dedicated cardiac CT imaging.
Scottish Funding Council
2024 - 2025
Supervision
- Huang, Shiting
Computational modelling of changes in the right ventricular function following lung resection